Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Open-label Clinical Study of hLB-001 Gene Therapy in Pediatric Patients With Methylmalonic Acidemia Characterized by MMUT Mutations
Conditions
Interventions
hLB-001
Locations
4
United States
Clinical Trial Site
Atlanta, Georgia, United States
Clinical Trial Site
Pittsburgh, Pennsylvania, United States
Clinical Trial Site
Nashville, Tennessee, United States
Clinical Trial Site
Seattle, Washington, United States
Start Date
May 29, 2021
Primary Completion Date
January 10, 2023
Completion Date
January 10, 2023
Last Updated
February 23, 2024
NCT04176523
NCT06664840
NCT05778877
NCT05438485
NCT05910151
NCT03810690
Lead Sponsor
LogicBio Therapeutics, Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions